Limits...
Prevalence of modifiable cardiovascular risk factors in long-term renal transplant patients.

Vivek V, Bhandari S - Int J Nephrol Renovasc Dis (2010)

Bottom Line: Multivariable analysis was performed on those factors found to achieve a P value of less than 0.20 after univariate analysis to test for significance in relation to cardiovascular risk as the primary factor.Univariate analysis revealed diabetes and age, and subsequent multivariable analysis revealed age only, as being significantly associated with cardiovascular outcomes.Age is an important determinant of cardiovascular risk.

View Article: PubMed Central - PubMed

Affiliation: Department of Renal Medicine, Hull and East Yorkshire Hospitals NHS Trust and Hull York Medical School, East Yorkshire, UK.

No MeSH data available.


Related in: MedlinePlus

Glycemic control as measured by HBA1c levels and fasting glucose in transplant patients with (NODAT) and without (ND) new onset diabetes after transplantation.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3108770&req=5

f1-ijnrd-3-175: Glycemic control as measured by HBA1c levels and fasting glucose in transplant patients with (NODAT) and without (ND) new onset diabetes after transplantation.

Mentions: NODAT patients were significantly older (P = 0.001), but there was no difference in gender and history of smoking. NODAT was more common in patients with polycystic kidney disease (16.7% versus 10%) and in patients with analgesic nephropathy (13.3% versus 4.4%) as a cause of renal disease (Table 2). Most patients received double or triple immunosuppressive therapy (97% and 93% for NODAT and ND, respectively). Both glucose and HBA1c concentrations were significantly elevated in NODAT (P < 0.001, Figure 1) but the levels in this group were adequately controlled.


Prevalence of modifiable cardiovascular risk factors in long-term renal transplant patients.

Vivek V, Bhandari S - Int J Nephrol Renovasc Dis (2010)

Glycemic control as measured by HBA1c levels and fasting glucose in transplant patients with (NODAT) and without (ND) new onset diabetes after transplantation.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3108770&req=5

f1-ijnrd-3-175: Glycemic control as measured by HBA1c levels and fasting glucose in transplant patients with (NODAT) and without (ND) new onset diabetes after transplantation.
Mentions: NODAT patients were significantly older (P = 0.001), but there was no difference in gender and history of smoking. NODAT was more common in patients with polycystic kidney disease (16.7% versus 10%) and in patients with analgesic nephropathy (13.3% versus 4.4%) as a cause of renal disease (Table 2). Most patients received double or triple immunosuppressive therapy (97% and 93% for NODAT and ND, respectively). Both glucose and HBA1c concentrations were significantly elevated in NODAT (P < 0.001, Figure 1) but the levels in this group were adequately controlled.

Bottom Line: Multivariable analysis was performed on those factors found to achieve a P value of less than 0.20 after univariate analysis to test for significance in relation to cardiovascular risk as the primary factor.Univariate analysis revealed diabetes and age, and subsequent multivariable analysis revealed age only, as being significantly associated with cardiovascular outcomes.Age is an important determinant of cardiovascular risk.

View Article: PubMed Central - PubMed

Affiliation: Department of Renal Medicine, Hull and East Yorkshire Hospitals NHS Trust and Hull York Medical School, East Yorkshire, UK.

No MeSH data available.


Related in: MedlinePlus